Health

More Evidence for Lower Ribociclib Dose in Advanced Breast Cancer

TribeNews
By TribeNews Add a Comment
0 Min Read
More Evidence for Lower Ribociclib Dose in Advanced Breast Cancer

MedPage Today) — A lower dose of the CDK4/6 inhibitor ribociclib (Kisqali) managed toxicity without compromising efficacy for women with hormone receptor (HR)-positive/HER2-negative breast cancer, according to results from two studies.
A phase…

Leave a Comment
Ads Blocker Image Powered by Code Help Pro

Ads Blocker Detected & This Is Prohibited!!!

We have detected that you are using extensions to block ads and you are also not using our official app. Your Account Have been Flagged and reported, pending de-activation & All your earning will be wiped out. Please turn off the software to continue

You cannot copy content of this app